This inventor holds 1 USPTO granted patent. Top assignees: Meshaberase, LLC, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3 
1 out of 3,699 
Years Active: 2026
Title: Benjamin Rubin: Inventor in Cancer Research
Introduction
Benjamin Rubin is an inventor based in Potomac, Maryland. His patent work addresses approaches to suppressing tumor metastasis and treating pancreatic cancer.
Latest Patents
Rubin is associated with 1 patent, titled “Use of Cysteamine and Derivatives Thereof to Suppress Tumor Metastases.” The disclosure describes methods for inhibiting or suppressing tumor metastasis in a mammalian subject using cysteamine, cystamine, or a derivative. It also describes administering a cysteamine product as a method for treating pancreatic cancer.
Career Highlights
Rubin’s patent affiliations include Meshaberase, LLC, and the United States of America, as represented by the Secretary of the Department of Health and Human Services.
Collaborations
His listed coworkers include Mark Gilbert and Jinkyu Jung.
Conclusion
Benjamin Rubin’s patent work focuses on cysteamine-based approaches to addressing tumor metastasis and pancreatic cancer.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile